INmune Bio Inc. to Report First Quarter 2026 Financial Results and Provide Corporate Update on Thursday, May 7th

Go back to INmune Bio Inc. to Report First Quarter 2026 Financial Results and Provide Corporate Update on Thursday, May 7th
(NASDAQ: INMB) Delayed: 1.43 -0.02 (1.38%)
Previous Close $1.45    52 Week High
Open $1.41    52 Week Low
Day High $1.48    P/E N/A 
Day Low $1.35    EPS
Volume 284,421